*Alnylam is proud to feature real patients in our advertising. Patients may or may not be on an Alnylam therapy.
Dosing for OXLUMO
OXLUMO is given by a healthcare provider as an injection under the skin in the abdomen, thighs, or upper arms. Dosing is based on the patient’s weight.
For patient on hemodialysis, OXLUMO will be administered after hemodialysis if administered on dialysis days.
For more information about how OXLUMO is given, talk to your doctor.
You can also refer to the Prescribing Information to learn more.
How OXLUMO is given
OXLUMO is an injection administered by a healthcare provider.
- Injections are given under the skin
- Injection sites can include the abdomen, thighs, or upper arms
- Doses are usually given in a doctor’s office, though some patients may qualify for in-home nursing support, depending on their insurance coverage and doctor's recommendations
Want to know more about in-home nursing?
CONNECT WITH AN ALNYLAM EDUCATOR
Learn about primary hyperoxaluria type 1 (PH1) and treatment with OXLUMO® from one of our trained Alnylam Patient Education Liaisons (PELs).
PELs are employees of Alnylam Pharmaceuticals. They are not acting as healthcare providers and are not part of your healthcare team.